Business Segments · Total Assets
MEDTECH — Total Assets
Johnson & Johnson MEDTECH — Total Assets decreased by 0.4% to $86.18B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.3%, from $85.11B to $86.18B. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ4 2018
Last reportedQ1 2026Apr 22, 2026
Rolls up toTotal Assets
How to read this metric
Growth in assets generally supports future revenue expansion, provided the return on those assets remains stable.
Detailed definition
This represents the total book value of resources owned or controlled by the medical technology segment, including inven...
Peer comparison
Standard segment-level balance sheet metric for diversified industrial and healthcare companies.
Metric ID:
jnj_segment_medtech_assetsHistorical Data
9 periods
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $53.37B | $70.96B | $74.71B | $84.32B | $85.11B | $86.75B | $86.50B | $86.48B | $86.18B |
| QoQ Change | — | +32.9% | +5.3% | +12.9% | +0.9% | +1.9% | -0.3% | -0.0% | -0.4% |
| YoY Change | — | +32.9% | +5.3% | +12.9% | — | — | — | +2.6% | +1.3% |
Range$53.37B – $86.75B
CAGR+27.1%
Avg YoY Growth+11.0%
Median YoY Growth+5.3%
Current Streak3 quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's medtech — total assets?
- Johnson & Johnson (JNJ) reported medtech — total assets of $86.18B in Q1 2026.
- How has Johnson & Johnson's medtech — total assets changed year-over-year?
- Johnson & Johnson's medtech — total assets increased by 1.3% year-over-year, from $85.11B to $86.18B.
- What does medtech — total assets mean?
- The total value of all resources and assets dedicated to the medical technology business.